Full name
BODYCLINIC SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ SPÓŁKA KOMANDYTOWA
uses securityreCAPTCHA
BODYCLINIC SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ SPÓŁKA KOMANDYTOWA
UL. JÓZEFA SIERAKOWSKIEGO 4 / U3, 03-712 WARSZAWA
TAX ID5252800889
Rate company:
BODYCLINIC SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ SPÓŁKA KOMANDYTOWA
TAX ID5252800889
KRS0000803546
address
UL. JÓZEFA SIERAKOWSKIEGO 4 / U3, 03-712 WARSZAWA
Website
www.bodyclinic.plCategories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
5252800889
REGON
384349587
KRS
0000803546
Legal form
limited partnership
Register Address
UL. JÓZEFA SIERAKOWSKIEGO 4 / U3, 03-712 WARSZAWA
Date of registration in KRS
2019-09-11
Date of commencement of economic activity
2019-09-11
Act signature
RDF/619449/24/127
Website
WWW.BODYCLINIC.PL
Pkd codes
86.22.Z - Specialist medical practice activities
47.73.Z - Dispensing chemist in specialised stores
72.19.Z - Other research and experimental development on natural sciences and engineering
86.10.Z - Hospital activities
86.21.Z - General medical practice activities
86.23.Z - Dental practice activities
86.90.A - Physiotherapeutical activities
86.90.C - Nurses and midwives activities
86.90.D - Paramedical activities
86.90.E - Other human health activities notelsewhere classified
Payer VAT status
Active
Vat list bank account(s)
PL30 1140 2062 0000 4863 4700 1001 
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale  | -0,3 | 0,6 | 1 | 80,8 |
Gross profit (loss) | -0,4 | 0,5 | 0,9 | 104 |
EBITDA | -0 | 1 | 1,5 | 48,7 |
Short time liabilities | 3,4 | 0,5 | 0,4 | -14 |
Other operating costs | 0 | 0 | 0 | -95,6 |
Income tax | 0 | |||
Equity capital | -0,5 | -0,2 | 0,6 | 385,3 |
Operating profit (EBIT) | -0,3 | 0,6 | 1,1 | 85,2 |
Assets | 3,3 | 3 | 4,1 | 37,4 |
Net profit (loss) | -0,4 | 0,4 | 0,8 | 89,2 |
Cash | 0 | 0,4 | 0,8 | 132,3 |
Net income from sale | 4,2 | 8,6 | 11,8 | 36,6 |
Liabilities and provisions for liabilities | 3,8 | 3,2 | 3,6 | 10,7 |
Working assets | 0,7 | 0,5 | 2 | 274,3 |
Other income costs | 0 | 0 | 0 | 1158,5 |
Depreciation | 0,3 | 0,5 | 0,5 | 2,5 |
Basic operational activity income | 0 | |||
% | % | % | p.p. | |
Profitability of capital | 73,9 | -203,7 | 135 | 338,7 |
Equity capital to total assets | -15,2 | -6,7 | 14 | 20,7 |
Gross profit margin | -8,7 | 5,3 | 8 | 2,7 |
EBITDA Margin | -0,7 | 12,1 | 13,1 | 1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 294 | 22 | 14 | -8 |
Current financial liquidity indicator | 0.20205523073673248 | 1.015403389930725 | 4.419943809509277 | 3,4 |
Net dept to EBITDA | -43.475067138671875 | 3.5803420543670654 | 1.3132753372192383 | -2,3 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdfShow more (1)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.